Review
Clinical practice and public policy for influenza and pneumococcal vaccination of the elderly
Affiliations
- PMID: 1576575
Item in Clipboard
Review
Clinical practice and public policy for influenza and pneumococcal vaccination of the elderly
Clin Geriatr Med.
1992 Feb.
Abstract
Influenza and pneumococcal vaccines are safe, effective, and cost-effective, but they are not used widely. Organized programs for vaccine delivery can lead to substantial improvements in vaccination rates for the elderly. Adequate reimbursement by Medicare and other third-party payers needs to be supplemented by educational programs to promote influenza and pneumococcal vaccines if the opportunity vaccination presents to improve the health and well-being of elderly persons is to be fully realized.
Similar articles
-
Prevention of respiratory infections in adults. Influenza and pneumococcal vaccines.Arch Intern Med. 1994 Nov 28;154(22):2545-57. Arch Intern Med. 1994. PMID: 7979851 Review.
-
Missed opportunities for pneumococcal and influenza vaccination of Medicare pneumonia inpatients--12 western states, 1995.MMWR Morb Mortal Wkly Rep. 1997 Oct 3;46(39):919-23. MMWR Morb Mortal Wkly Rep. 1997. PMID: 9347905
-
Pneumococcal and influenza vaccination levels among adults aged > or = 65 years--United States, 1995.MMWR Morb Mortal Wkly Rep. 1997 Oct 3;46(39):913-9. MMWR Morb Mortal Wkly Rep. 1997. PMID: 9347904
-
Influenza and pneumococcal vaccination levels among adults aged > or =65 years--United States, 1997.MMWR Morb Mortal Wkly Rep. 1998 Oct 2;47(38):797-802. MMWR Morb Mortal Wkly Rep. 1998. PMID: 9776166
-
Pneumococcal vaccination. Controversies and opportunities.Infect Dis Clin North Am. 1990 Mar;4(1):11-27. Infect Dis Clin North Am. 1990. PMID: 2407776 Review.
Cited by
-
The cost effectiveness of pneumococcal vaccination strategies.Pharmacoeconomics. 1997 Aug;12(2 Pt 1):161-74. doi: 10.2165/00019053-199712020-00006. Pharmacoeconomics. 1997. PMID: 10169668 Review.
-
Efficacy of influenza vaccine among elderly patients by physical activity status.Environ Health Prev Med. 2002 Nov;7(5):183-8. doi: 10.1007/BF02898002. Environ Health Prev Med. 2002. PMID: 21432275 Free PMC article.
-
Economic evaluation of influenza vaccination and economic modelling. Can results be pooled?Pharmacoeconomics. 1996;9 Suppl 3:67-72. doi: 10.2165/00019053-199600093-00015. Pharmacoeconomics. 1996. PMID: 10160490
-
Removing barriers to vaccination use by older adults.Drugs Aging. 1994 May;4(5):357-65. doi: 10.2165/00002512-199404050-00001. Drugs Aging. 1994. PMID: 8043938 Review. No abstract available.
-
Targeting pneumococcal vaccination to high-risk groups: a feasibility study in one general practice.Postgrad Med J. 1999 Apr;75(882):208-12. doi: 10.1136/pgmj.75.882.208. Postgrad Med J. 1999. PMID: 10715759 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical